Home

Kenneth A. Lock, Chief Commercial Officer: Arcutis Biotherapeutics ARQT Sell · Filed 23/03/02

Trade details

Type
Insider sale
Amount
$22,369.48
Shares · price
1,414 sh · $15.82 a share
Held after
43,278 sh
Trade date
23/03/02
Filed
23/03/02
Days to filing
0 days

Sold 3.2% of holdings

Share of holding sold
3.2%

Arcutis Biotherapeutics trades, last 26 weeks

What else happened in Arcutis Biotherapeutics around then

Filed or reported within 30 days of the trade day · 23/01/31~23/04/01

Kenneth A. Lock's recent trades

  • Kenneth A. Lock

    SellArcutis Biotherapeutics

    $12.7K

    Filed 23/03/08

  • Kenneth A. Lock

    SellArcutis Biotherapeutics

    $15.1K

    Filed 23/03/02

  • Kenneth A. Lock

    SellArcutis Biotherapeutics

    $297

    Filed 23/03/02